NINGDE, China, June  24, 2026  (GLOBE NEWSWIRE) --  Oriental Rise Holdings Limited (NASDAQ:ORIS) (&#34;Oriental Rise&#34; or the &#34;Company&#34;), an integrated tea supplier in mainland China, today provided an update

ORIS

Oriental Rise Provides Update Regarding Nasdaq Delisting Decision and Request for Reconsideration

ORIS Delisting decision triggers OTC transition and reconsideration process

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NINGDE, China, June  24, 2026  (GLOBE NEWSWIRE) --  Oriental Rise Holdings Limited (NASDAQ:ORIS) (&amp;#34;Oriental Rise&amp;#34; or the &amp;#34;Company&amp;#34;), an integrated tea supplier in mainland China, today provided an update</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Oriental Rise Holdings faced Nasdaq&#039;s delisting decision and trading suspension despite a June 22 reverse split that left post-split prices above $1. The company will pursue reconsideration and potential appeal, with OTC trading likely under ORISF if unresolved. Near-term liquidity and valuation risk dominates until a regulatory outcome is known.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Nasdaq Panel denies continued listing for ORIS. Trading suspended at market open June 24, 2026.</li><li>1-for-4 reverse stock split effective June 22; opened $2.04, closed $2.42.</li><li>Panel denies listing; reconsideration ongoing.</li><li>If unresolved, ORIS may trade OTC under ORISF; no guaranteed resume.</li><li>Company states business operations unaffected and will pursue reconsideration.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Oriental Rise Holdings Limited (ORIS)</strong>: Subject to Nasdaq delisting; trading suspended; may move to OTC ORISF; fundamental operations unchanged.</li><li><strong>Nasdaq, Inc. (NDAQ)</strong>: Regulatory venue issuing delisting decision; directly influencing ORIS liquidity and listing status.</li><li><strong>ORISF (ORISF)</strong>: OTC trading symbol likely if ORIS does not regain Nasdaq listing; liquidity typically limited.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. The piece centers on a regulatory listing action and its implications for ORIS liquidity and trading venue, with a potential OTC transition and reconsideration process driving near-term uncertainty.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Nasdaq delisting creates immediate liquidity risk and potential OTC transition for ORIS.</li><li>The reverse split produced a post-split price above $1, but relisting remains uncertain.</li><li>OTC trading under ORISF could reduce liquidity and price discovery for investors.</li><li>Regulatory reconsideration timeline remains open, with no guaranteed resolution.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>May 19, 2026: oral hearing before Nasdaq Listing Qualification Panel on minimum bid price deficiency.</li><li>June 22, 2026: 1-for-4 reverse stock split became effective; open $2.04, close $2.42.</li><li>June 22, 2026: Nasdaq Panel denied continued listing for ORIS.</li><li>June 24, 2026: trading in ORIS shares suspended on Nasdaq; OTC transition possible.</li><li>ORISF is the OTC trading symbol referenced for potential secondary trading.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>ORIS remains a high-risk, high-uncertainty play with likely OTC trading and potential further downside unless Nasdaq reversal occurs within weeks to months.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>NINGDE, China, June  24, 2026  (GLOBE NEWSWIRE) --  Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ORIS">ORIS</a>) (&#34;Oriental Rise&#34; or the &#34;Company&#34;), an integrated tea supplier in mainland China, today provided an update regarding the decision of the Nasdaq Hearings Panel (the &#34;Panel&#34;) to delist the Company’s ordinary shares from The Nasdaq Capital Market.</p>  <p>Following the May 19, 2026 oral hearing before the Nasdaq Listing Qualification Panel where the Company outlined its plan of compliance with the $1.00 per share minimum bid price deficiency, on June 22, 2026, the Company received a written decision from the Panel denying the Company’s request for continued listing and providing that trading in the Company’s ordinary shares would be suspended at the open of trading on June 24, 2026.</p>  <p>Prior to the issuance of the Panel’s decision, the Company’s previously announced 1-for-4 reverse stock split became effective at the open of trading on June 22, 2026. On that day, the Company’s ordinary shares opened at $2.04 per share and closed at $2.42 per share, materially above Nasdaq’s $1.00 minimum bid price requirement.</p>  <p>Because the reverse stock split had already become effective and in light of the post-split trading levels in the Company’s securities, the Company submitted an emergency request for a stay of the suspension and reconsideration of the Panel’s delisting decision on the evening of June 22, 2026.</p>  <p>On June 23, 2026, the Company’s counsel received an email from Nasdaq stating that the Panel was reviewing the Company’s request for reconsideration, that the Company would be notified within 15 calendar days, and that the Panel had chosen to stay the suspension while considering the request.</p>  <p>On June 24, 2026, Nasdaq advised the Company’s counsel that its prior email had inadvertently omitted the word &#34;not&#34; and should instead have stated that the Panel, in fact, had chosen not to stay the suspension. Accordingly, trading in the Company’s ordinary shares on Nasdaq was suspended, while the Panel continued to consider the Company’s request for reconsideration, which consideration is ongoing, to the best of the Company’s knowledge.</p>  <p>The Company believes that the effectiveness of the reverse stock split and the resulting post-split trading price, among other factors, are material developments relevant to the Panel’s assessment of the Company’s ability to regain and maintain compliance with Nasdaq Listing Rule 5550(a)(2). The Company will continue to pursue its request for reconsideration.</p>  <p>If the Panel does not reconsider its decision, the Company currently intends to request that the Nasdaq Listing and Hearing Review Council review the Panel’s decision. There can be no assurance that the Panel will grant reconsideration, that any appeal will be successful, or that the Company’s ordinary shares will resume trading on Nasdaq.</p>  <p>Unless and until the Panel reverses or modifies its decision, or the Company is successful in a subsequent appeal, the Company expects that its ordinary shares will be quoted in the over-the-counter market. Shareholders should consult their brokers regarding the availability of quotations and trading under the Company’s OTC trading symbol, ORISF.</p>  <p>The suspension from Nasdaq does not affect the Company’s business operations, corporate organization, or obligation to continue complying with applicable U.S. Securities and Exchange Commission reporting requirements.</p>  <p><b>About Oriental Rise Holdings Limited</b></p>  <p>Oriental Rise Holdings Limited is an integrated supplier of tea products in mainland China. Its major tea products include primarily-processed tea consisting of white tea and black tea, as well as refined white tea and black tea. The Company’s business operations are vertically integrated, covering tea cultivation, processing of tea leaves, and the sale of tea products to tea business operators, such as wholesale distributors, and end-user retail customers in mainland China. The Company operates tea gardens located in Zherong County, Ningde City in Fujian Province of mainland China.</p>  <p><b>Forward-Looking Statements</b></p>  <p>Certain statements in this announcement are forward-looking statements, including, without limitation, statements regarding the Company’s request for reconsideration, any potential appeal, the possible resumption of trading on Nasdaq, quotation of the Company’s ordinary shares in the over-the-counter market, and the Company’s ability to regain or maintain compliance with applicable listing requirements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Words such as &#34;believes,&#34; &#34;expects,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;may,&#34; &#34;will,&#34; and similar expressions are intended to identify forward-looking statements.</p>  <p>The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law. Investors are cautioned that actual results may differ materially from those described in the forward-looking statements.</p>  <p>For investor and media inquiries, please contact:</p>  <p>Oriental Rise Holdings Limited<br></br>Investor Relations Department<br></br>Email: <a href="https://www.globenewswire.com/Tracker?data=6pA28acZ7tVNnhTkB4BEHQzteTHvSeLeRoAqREgaupQRm4RwQUHCMXowNBbSg7_6_4cmpT-7c315AT_7iPZaqA==" rel="nofollow" target="_blank">ir@mdhtea.cn</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTc1MjIxNSM3Njc3MzI3IzUwMDEyODg3Ng=="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/ZDA0ZmM4MDEtNGQzMy00OWNiLTkzNTMtY2RhYmJjYTY0OTUyLTUwMDEyODg3Ni0yMDI2LTA2LTI0LWVu/tiny/Oriental-Rise-Holdings-Limited.png" referrerpolicy="no-referrer-when-downgrade"></img>

Oriental Rise Holdings faced Nasdaq's delisting decision and trading suspension despite a June 22 reverse split that left post-split prices above $1. The company will pursue reconsideration and potential appeal, with OTC trading likely under ORISF if unresolved. Near-term liquidity and valuation risk dominates until a regulatory outcome is known.

Oriental Rise Provides Update Regarding Nasdaq Delisting Decision and Request for Reconsideration

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News